Antidiabetic compounds comprising benzofuran and benzothiophene derivatives

Details for Australian Patent Application No. 2004295029 (hide)

Owner Merck Patent GmbH

Inventors Kergoat, Micheline; Moinet, Gerard; Leriche, Caroline

Agent Davies Collison Cave

Pub. Number AU-B-2004295029

PCT Pub. Number WO2005/054225

Priority 0313612 20.11.03 FR

Filing date 26 October 2004

Wipo publication date 16 June 2005

Acceptance publication date 11 March 2010

International Classifications

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/381 (2006.01) - having five-membered rings

C07D 307/83 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/64 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 333/68 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 333/70 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

13 July 2006 PCT application entered the National Phase

  PCT publication WO2005/054225 Priority application(s): WO2005/054225

11 March 2010 Application Accepted

  Published as AU-B-2004295029

8 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004295032-Amine derivatives

2004295023-Single-chain insulin